Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07540052 · ClinicalTrials.gov registry record · NA
Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise Adherence in Older Adults
A NA study, sponsored by Milton S. Hershey Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT07540052: Clinical Trial NA study, sponsored by Milton S. Hershey Medical Center.
NCT07540052 is a NA study that has not yet begun recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07540052, a NA study, has not yet begun recruiting, sponsored by Milton S. Hershey Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if messages focused on not losing the functional benefits of exercise can help older adults with walking difficulty continue to exercise regularly. The main questions it aims to answer are: Do these messages make people more likely to anticipate regretting it if they do not exercise? Does more anticipated regret make it more likely they will exercise more regularly? Researchers will compare two versions of messages to see if the content of these one of these message types is more effective than the other. Participants will complete a daily 5-minute at home exercise program for 4 months and complete regular online surveys to track their progress and report their feelings regarding regret.
Primary Outcome
One is equivalent to definitely not anticipating regret and 8 indicates definitely anticipating regret.
Interventions
- BEHAVIORAL Brief Daily At-Home Strength Training Program
- BEHAVIORAL Loss Aversion Messaging
- BEHAVIORAL Standard Adherence Reminder Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-07 |
| Phase | NA |
What is known before NCT07540052 opens enrollment
NCT07540052 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Brief Daily At-Home Strength Training Program is the first listed.
NCT07540052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07540052 about?
NCT07540052 is a clinical study titled "Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise Adherence in Older Adults". The goal of this clinical trial is to learn if messages focused on not losing the functional benefits of exercise can help older adults with walking difficulty continue to exercise regularly. The main questions it aims to answer are: Do these messages make people more likely to anticipate regrettin...
What is the current status of trial NCT07540052?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2026-06. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07540052?
The interventions under investigation include: Brief Daily At-Home Strength Training Program (BEHAVIORAL), Loss Aversion Messaging (BEHAVIORAL), Standard Adherence Reminder Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT07540052?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07540052's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia